Industry Focus

After Puma Biotech's recent success, the search is on for other clinical-stage biotech stocks being run by proven CEOs. Could experience turn Aurinia Pharmaceuticals, Axovant Sciences, and Esperion Therapeutics into winners too?

Thanks to Slack for supporting Motley Fool. Learn more at slack.com.

 

Direct download: 20170719_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT

1